Association Between Adverse Effects Under Azathioprine Therapy and Inosine Triphosphate Pyrophosphatase Activity in Patients With Chronic Inflammatory Bowel Disease

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Therapeutic Drug Monitoring

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/FTD.0b013e31821a7c34PMID 21544018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Are patients with intermediate TPMT activity at increased risk of myelosuppression when taking thiopurine medications?

  2010cited by this paper
• Thiopurines: factors influencing toxicity and response.

  2010cited by this paper
• Pharmacogenetics of thiopurines in inflammatory bowel disease.

  2010cited by this paper
• Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease.

  2010cited by this paper
• Association between inosine triphosphate pyrophosphohydrolase deficiency and azathioprine‐related adverse drug reactions in the Chinese kidney transplant recipients

  2009cited by this paper
• TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients

  2009cited by this paper
• On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.

  2009cited by this paper
• Thiopurine S-methyltransferase and inosine triphosphate pyrophosphohydrolase genes in Japanese patients with inflammatory bowel disease in whom adverse drug reactions were induced by azathioprine/6-mercaptopurine treatment

  2009cited by this paper
• Individualization of thiopurine therapy: thiopurine S-methyltransferase and beyond.

  2009cited by this paper
• Genetic variations in the HGPRT, ITPA, IMPDH1, IMPDH2, and GMPS genes in Japanese individuals.

  2009cited by this paper
• Genetic Polymorphism of Inosine Triphosphate Pyrophosphatase Is a Determinant of Mercaptopurine Metabolism and Toxicity During Treatment for Acute Lymphoblastic Leukemia

  2009cited by this paper
• The Increasing Complexity of Mercaptopurine Pharmacogenomics

  2009cited by this paper
• Pharmacogenomic studies of the anticancer and immunosuppressive thiopurines mercaptopurine and azathioprine.

  2008cited by this paper
• Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel disease

  2008cited by this paper
• Diagnostik und Therapie des Morbus Crohn: Ergebnisse einer Evidenz-basierten Konsensuskonferenz der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten zusammen mit dem Kompetenznetz Chronisch entzündliche Darmerkrankungen

  2008cited by this paper
• S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn”

  2008cited by this paper
• Sequential evaluation of thiopurine methyltransferase, inosine triphosphate pyrophosphatase, and HPRT1 genes polymorphisms to explain thiopurines' toxicity and efficacy

  2007cited by this paper
• Analysis of ITPA Phenotype-Genotype Correlation in the Bulgarian Population Revealed a Novel Gene Variant in Exon 6

  2007cited by this paper
• Pharmacogenetic significance of inosine triphosphatase.

  2007cited by this paper
• Meta‐analysis: inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease

  2007cited by this paper
• Pharmacogenetics of thiopurine therapy in paediatric IBD patients

  2006cited by this paper
• Measurement of erythrocyte inosine triphosphate pyrophosphohydrolase (ITPA) activity by HPLC and correlation of ITPA genotype-phenotype in a Caucasian population.

  2006influential reference
• Hepatotoxicity of chemotherapy.

  2006cited by this paper
• Inosine triphosphate pyrophosphatase and thiopurine s-methyltransferase genotypes relationship to azathioprine-induced myelosuppression.

  2006cited by this paper
• ITPA genotyping test does not improve detection of Crohn’s disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression

  2005cited by this paper
• Association of inosine triphosphatase 94C>A and thiopurine S-methyltransferase deficiency with adverse events and study drop-outs under azathioprine therapy in a prospective Crohn disease study.

  2005cited by this paper
• Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency in the Japanese population.

  2005cited by this paper
• Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation

  2005cited by this paper
• Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).

  2004cited by this paper
• [Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease].

  2004cited by this paper
• Lack of association between the ITPA 94C>A polymorphism and adverse effects from azathioprine.

  2004cited by this paper
• Rapid detection of ITPA 94C>A and IVS2 + 21A>C gene mutations by real-time fluorescence PCR and in vitro demonstration of effect of ITPA IVS2 + 21A>C polymorphism on splicing efficiency.

  2004cited by this paper
• Distribution of ITPA P32T alleles in multiple world populations

  2004cited by this paper
• Determination of Thiopurine Methyltransferase Phenotype in Isolated Human Erythrocytes Using a New Simple Nonradioactive HPLC Method

  2003cited by this paper
• [Hepatotoxicity of chemotherapy].

  2003cited by this paper
• Genetic basis of inosine triphosphate pyrophosphohydrolase deficiency

  2002cited by this paper
• Cloning, Expression, and Characterization of a Human Inosine Triphosphate Pyrophosphatase Encoded by the ITPAGene*

  2001cited by this paper
• Azathioprine Pharmacogenetics: The Relationship between 6-Thioguanine Nucleotides and Thiopurine Methyltransferase in Patients after Heart and Kidney Transplantation

  1996cited by this paper
• WHO Handbook for Reporting Results of Cancer Treatment

  1982cited by this paper
• Reporting results of cancer treatment

  1981cited by this paper

• Unraveling Novel Genetic Determinants of Thiopurine Response Via TWAS

  2025cites this paper
• Inosine Triphosphate Pyrophosphatase (ITPase): Functions, Mutations, Polymorphisms and Its Impact on Cancer Therapies

  2022cites this paper
• Clinico‐radiological features, molecular spectrum, and identification of prognostic factors in developmental and epileptic encephalopathy due to inosine triphosphate pyrophosphatase (ITPase) deficiency

  2022cites this paper
• Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis.

  2022cites this paper
• Thiopurines in Inflammatory Bowel Disease. How to Optimize Thiopurines in the Biologic Era?

  2021cites this paper
• Structural dynamics of inosine triphosphate pyrophosphatase (ITPA) protein and two clinically relevant mutants: molecular dynamics simulations

  2020cites this paper
• Systematic review with meta‐analysis: risk factors for thiopurine‐induced leukopenia in IBD

  2019cites this paper
• Red Blood cell IMPDH activity in adults and children with or without azathioprine: Relationship between thiopurine metabolites, ITPA and TPMT activities

  2018cites this paper
• Revisiting the Role of Thiopurines in Inflammatory Bowel Disease Through Pharmacogenomics and Use of Novel Methods for Therapeutic Drug Monitoring

  2018cites this paper
• ITPA Activity in Children Treated by Azathioprine: Relationship to the Occurrence of Adverse Drug Reactions and Inflammatory Response

  2018cites this paper
• Variants in TPMT, ITPA, ABCC4 and ABCB1 Genes As Predictors of 6-mercaptopurine Induced Toxicity in Children with Acute Lymphoblastic Leukemia

  2018cites this paper
• Metabolic events in HIV-infected patients using abacavir are associated with erythrocyte inosine triphosphatase activity

  2018cites this paper
• ITPA Activity in Adults and Children Treated With or Without Azathioprine: Relationship Between TPMT Activity, Thiopurine Metabolites, and Co-medications

  2017cites this paper
• Determination of inosine 5'-monophosphate dehydrogenase activity in red blood cells of thiopurine-treated patients using HPLC.

  2017cites this paper
• Pharmacogenetics of inflammatory bowel disease: a focus on Crohn's disease.

  2017cites this paper
• Étude phénotypique des enzymes du métabolisme des thiopurines (ITPA, IMPDH), lien avec les métabolites thiopuriques et optimisation thérapeutique en gastro-entérologie

  2016influential citation
• Review article: recent advances in pharmacogenetics and pharmacokinetics for safe and effective thiopurine therapy in inflammatory bowel disease

  2016cites this paper
• Identification of ITPA on chromosome 20 as a susceptibility gene for young-onset tuberculosis

  2016cites this paper
• A disease spectrum for ITPA variation: advances in biochemical and clinical research

  2016cites this paper
• Effects of azathioprine, 6-mercaptopurine, and 6-thioguanine on canine primary hepatocytes.

  2015cites this paper
• Update on thiopurine pharmacogenetics in inflammatory bowel disease.

  2015cites this paper
• The impact of glutathione S-transferase genotype and phenotype on the adverse drug reactions to azathioprine in patients with inflammatory bowel diseases.

  2015cites this paper
• Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease.

  2015cites this paper
• Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects.

  2015cites this paper
• RETRACTED: Clinical significance of ITPA rs67002563 polymorphism in patients with acute lymphoblastic leukemia treated with 6-mercaptopurine.

  2015cites this paper
• Current stage in inflammatory bowel disease: What is next?

  2015cites this paper
• Glutathione transferases in the bioactivation of azathioprine.

  2014cites this paper
• Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy

  2014cites this paper
• Pharmacogenetics of inflammatory bowel disease.

  2014cites this paper
• Pharmacogenetics in rheumatoid arthritis.

  2014cites this paper
• Chapter 29 – Rheumatoid Arthritis

  2014cites this paper
• Determination of inosine triphosphate pyrophosphatase in red blood cells using HPLC: an improved method.

  2014cites this paper
• ITPA (inosine triphosphate pyrophosphatase): from surveillance of nucleotide pools to human disease and pharmacogenetics.

  2013cites this paper
• Mutational Analysis and Redesign of Alpha-class Glutathione Transferases for Enhanced Azathioprine Activity

  2013cites this paper
• The human ITPA polymorphic variant P32T is destabilized by the unpacking of the hydrophobic core.

  2013cites this paper
• Personalized therapies in pediatric inflammatory and autoimmune diseases.

  2012cites this paper
• Polymorphism of Genes Involved in Purine Metabolism (XDH, AOX1, MOCOS) in Kidney Transplant Recipients Receiving Azathioprine

  2012cites this paper
• Determination of Inosine Triphosphate Pyrophosphatase Phenotype in Human Red Blood Cells Using HPLC

  2012cites this paper
• The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.

  2012cites this paper
• Current relevance of pharmacogenetics in immunomodulation treatment for Crohn's disease

  2012cites this paper
• Mercaptopurine-induced hypersensitivity febrile reaction in patient with acute promyelocytic leukemia

  2012cites this paper
• Acta Universitatis Upsaliensis Uppsala 2013 List of Papers

  year unknowncites this paper